Financial Performance - For the fiscal year ending December 31, 2023, the company reported a revenue increase of 156.7% to approximately HKD 80,218,000[10] - The profit attributable to equity shareholders rose by 166.5% to approximately HKD 7,658,000 for the same period[10] - Revenue from the photography services business reached approximately HKD 65,039,000, reflecting a growth of about 178.4%[12] - The medical services business generated revenue of approximately HKD 15,179,000, marking an increase of approximately 92.4%[14] - The company's revenue increased from approximately HKD 31,253,000 for the year ended December 31, 2022, to approximately HKD 80,218,000 for the year ended December 31, 2023, representing an increase of about 156.5%[32] - Photography services revenue rose approximately 178.4% to about HKD 65,039,000 for the year ended December 31, 2023, compared to HKD 23,362,000 for the previous year[32] - Medical services revenue increased to approximately HKD 15,179,000 for the year ended December 31, 2023, up from HKD 7,891,000 for the year ended December 31, 2022, reflecting a growth driven by increased patient visits[32] - The company's gross profit improved to approximately HKD 26,905,000 for the year ended December 31, 2023, with a gross profit margin of about 33.54%, compared to HKD 5,078,000 and a margin of 16.25% for the previous year[34] - Other income decreased from approximately HKD 2,073,000 for the year ended December 31, 2022, to about HKD 584,000 for the year ended December 31, 2023, primarily due to a reduction in rental revision income[35] - The company's profit attributable to owners increased from a loss of approximately HKD 11,518,000 for the year ended December 31, 2022, to a profit of approximately HKD 7,658,000 for the year ended December 31, 2023, primarily due to increased revenue from the Hong Kong photography services business[42] Business Strategy and Expansion - The company plans to establish or acquire new clinics and related medical businesses to expand its medical services portfolio[14] - The company is exploring various potential projects to enhance its photography services, including upgrading self-service photo booths and introducing IT infrastructure[12] - The board believes that further development of the medical services business is crucial for the company's diversification strategy[14] - The company plans to strengthen its photography services and expand its customer base while reallocating resources to develop its medical services business in response to the growing demand for healthcare[19] - The company is actively seeking to recruit suitable practitioners and establish new medical centers in Hong Kong, aligning with the government's primary healthcare blueprint[28] - The company aims to enhance its existing core businesses and explore new business opportunities for sustainable growth and shareholder value creation[29] - The company has established new medical centers in Hong Kong and is actively seeking suitable practitioners and equipment to expand its medical services[54] Dividends and Shareholder Returns - A special dividend of HKD 0.005625 per share, totaling HKD 4,500,000, has been proposed, pending approval at the upcoming annual general meeting[17] - The company has proposed an interim dividend of HKD 0.00375 per share, totaling HKD 3,000,000, which was approved by shareholders[63] - A special dividend of HKD 0.005625 per share, totaling HKD 4,500,000, is proposed for the year ending December 31, 2023, pending shareholder approval[63] - The board considers various factors, including financial performance and capital expenditure needs, before declaring dividends[122] Financial Position and Ratios - Total equity increased to approximately HKD 27,945,000 as of December 31, 2023, from HKD 22,714,000 as of December 31, 2022[47] - Cash and cash equivalents amounted to approximately HKD 25,669,000 as of December 31, 2023, compared to HKD 21,699,000 as of December 31, 2022[47] - The current ratio and quick ratio were 1.95 and 1.87, respectively, as of December 31, 2023, compared to 1.92 and 1.87 as of December 31, 2022[47] - The company had bank loans of approximately HKD 1,000,000 as of December 31, 2023, unchanged from the previous year[47] - The company's total liabilities to total assets ratio was 48.7% as of December 31, 2023, down from 51.5% as of December 31, 2022[48] Risks and Compliance - The company faces currency risk primarily from cash and bank balances denominated in USD and RMB, with no hedging agreements currently in place[57] - The company relies on a professional team for its medical services, and any failure to attract or retain qualified professionals could adversely affect its financial performance[91] - The company emphasizes the importance of its reputation in the medical services sector, which could be negatively impacted by any negligence or legal issues, affecting its business and financial status[92] - The company has complied with all relevant laws and regulations, with no significant violations reported that could impact its operations[95] Corporate Governance - The company has adopted a corporate governance code in compliance with GEM Listing Rules and has adhered to all applicable provisions during the year[180] - The board consists of three executive directors, one non-executive director, and three independent non-executive directors, complying with the GEM Listing Rules regarding board composition[187] - The board has adopted a diversity policy and aims to appoint a director of a different gender by December 31, 2024[191] - All independent non-executive directors have confirmed their independence according to GEM listing rules, ensuring effective governance[191] - The company provides necessary onboarding training for new directors to ensure understanding of operations and responsibilities[194] - The roles of the chairman and CEO are clearly separated, with distinct responsibilities assigned to each[195] Share Options and Ownership - The company aims to encourage contributions from qualified individuals through its share option plan, which was adopted on February 8, 2018[139] - The share option plan is designed to reward past contributions and retain experienced personnel within the group[139] - The maximum number of shares to be issued under the share option plan shall not exceed 10% of the total issued shares at any time[142] - The total number of shares to be issued due to the exercise of all options granted to any eligible person within any 12-month period shall not exceed 1% of the total issued shares[145] - The beneficial ownership of Causeway Treasure is divided among Chen Yongji (47.25%), Chen Tianqi (47.25%), and Ouyang Yinghe (5.5%) as of December 31, 2023[136] Stakeholder Relationships - The group maintains strong relationships with key stakeholders, including employees, customers, and suppliers, with no significant disputes reported as of December 31, 2023[98] - The group does not rely on any single customer for its photography and medical services, ensuring a diversified customer base[103] - The group regularly reviews employee benefits and complies with local labor laws, providing medical insurance and other benefits[98] Auditor and Compliance - The auditor, KPMG, resigned on November 7, 2023, and the board appointed another firm to fill the vacancy[176] - The independent non-executive directors have reviewed the continuing connected transactions and confirmed that they were conducted under fair and reasonable terms, aligning with the overall interests of shareholders[162] - The auditor has stated that there are no matters of concern regarding the continuing connected transactions, which were established in accordance with regulatory agreements[163]
名仕快相(08483) - 2023 - 年度财报